Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|15|4|395-415

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.15, Iss.4, 2015-01, pp. : 395-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges

By  

Current Gene Therapy, Vol. 12, Iss. 3, 2012-06 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors

By  

Current Gene Therapy, Vol. 12, Iss. 3, 2012-06 ,pp. : 139-151

Bentham Science Publishers

Access to resources Recommend Favorite

Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite

Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles

By  

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 168-183

Bentham Science Publishers

Access to resources Recommend Favorite

Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3248-3256

Bentham Science Publishers

Access to resources Recommend Favorite